Work

1541P DNA immunotherapy (INO-3107) in HPV-6 & 11 recurrent respiratory papillomatosis: Long-term efficacy

Year: 2025

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.08.2172

Authors: N.F. Saba, M.R. Amin, P.C. Belafsky, S.R. Best, A.D. Friedman, A.M. Klein, D.G. Lott, T. Mau, R.C. Paniello, S.M. Pransky, C. Welsh, S. Slog, J. Skolnik

Institutions: Winship Cancer Institute, New York University, University of California Davis Medical Center, Johns Hopkins University, Johns Hopkins Medicine, University of Cincinnati, Emory University, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Arizona), The University of Texas Southwestern Medical Center, Washington University in St. Louis, Inovio Pharmaceuticals (United States)

Language: English

Topic: Cervical Cancer and HPV Research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415942091

FWCI:

Cites:

Cited by:

Related to: